Halterman T - Search Results

1

Schlenker C, Halterman T, Kowdley KV. Schlenker C, et al. Among authors: halterman t. Clin Liver Dis. 2011 Feb;15(1):153-64. doi: 10.1016/j.cld.2010.09.006. Clin Liver Dis. 2011. PMID: 21111998 Review.

2

Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.

Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ. Barnett MJ, et al. Among authors: halterman t. J Manag Care Pharm. 2009 Jan-Feb;15(1):18-31. doi: 10.18553/jmcp.2009.15.1.18. J Manag Care Pharm. 2009. PMID: 19125547 Free PMC article.

3

Anxiety and pain symptoms in children with inflammatory bowel disease and functional gastrointestinal disorders undergoing colonoscopy.

Crandall WV, Halterman TE, Mackner LM. Crandall WV, et al. Among authors: halterman te. J Pediatr Gastroenterol Nutr. 2007 Jan;44(1):63-7. doi: 10.1097/01.mpg.0000239733.79487.1e. J Pediatr Gastroenterol Nutr. 2007. PMID: 17204955

4

Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.

John EJ, Vavra T, Farris K, Currie J, Doucette W, Button-Neumann B, Osterhaus M, Kumbera P, Halterman T, Bullock T. John EJ, et al. Among authors: halterman t. Pharmacotherapy. 2006 Oct;26(10):1511-7. doi: 10.1592/phco.26.10.1511. Pharmacotherapy. 2006. PMID: 16999661

5

Outcomes-based pharmacist reimbursement: reimbursing pharmacists for cognitive services part 1.

Farris KB, Kumbera P, Halterman T, Fang G. Farris KB, et al. Among authors: halterman t. J Manag Care Pharm. 2002 Sep-Oct;8(5):383-93. doi: 10.18553/jmcp.2002.8.5.383. J Manag Care Pharm. 2002. PMID: 14613406

6

Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.

Dutta AS, Gormley JJ, Coath M, Hassall L, Hayward CF, Gellert PR, Kittlety RS, Alcock PJ, Ferguson R, Halterman T, Jamieson A, Moors JA, Moores JM, Rees A, Wood LJ, Reilly CF, Haworth D. Dutta AS, et al. Among authors: halterman t. J Pept Sci. 2000 Aug;6(8):398-412. doi: 10.1002/1099-1387(200008)6:8<398::AID-PSC270>3.0.CO;2-1. J Pept Sci. 2000. PMID: 10969869

7

ZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.

Howe BB, Halterman TJ, Yochim CL, Do ML, Pettinger SJ, Stow RB, Ohnmacht CJ, Russell K, Empfield JR, Trainor DA, et al. Howe BB, et al. Among authors: halterman tj. J Pharmacol Exp Ther. 1995 Aug;274(2):884-90. J Pharmacol Exp Ther. 1995. PMID: 7636752

8

Characterization of ATP-sensitive potassium channel-blocking activity of ZENECA ZM181,037, a eukalemic diuretic.

Kau ST, Zografos P, Do ML, Halterman TJ, McConville MW, Yochim CL, Trivedi S, Howe BB, Li JH. Kau ST, et al. Among authors: halterman tj. Pharmacology. 1994 Oct;49(4):238-48. doi: 10.1159/000139239. Pharmacology. 1994. PMID: 7831387

9

Diuretic and antihypertensive activity of ZENECA ZM224,832: a novel eukalemic diuretic with calcium channel blocking activity.

Kau ST, Halterman TJ, Yochim CL, Howe BB, Li JH, Schwartz JA. Kau ST, et al. Among authors: halterman tj. Pharmacology. 1994 Mar;48(3):167-75. doi: 10.1159/000139176. Pharmacology. 1994. PMID: 8153144

10

ICI 206,970: a novel calcium channel blocker with eukalemic diuretic activity.

Howe BB, Keith RA, Do ML, Halterman TJ, Donahue JY, Schwartz JA, Kau ST. Howe BB, et al. Among authors: halterman tj. Pharmacology. 1993 Dec;47(6):369-77. doi: 10.1159/000139120. Pharmacology. 1993. PMID: 8278459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page